N4 PHARMA PLC

Regulatory Filings • Feb 3, 2025

National Storage Mechanism | Additional information

RNS Number : 7230V

Ananda Pharma PLC

03 February 2025

3 February 2025

ANANDA PHARMA PLC  

("Ananda" or the "Company")

Change of Registered Office

Ananda (AQSE: ANA), a Company focused on the development of cannabinoid therapies for the treatment of a range of complex conditions, announces that it has moved its registered office to c/o Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, EC2N 4BQ.

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement. 

For further information, please contact:

ANANDA DEVELOPMENTS PLC	+44 (0)7463 686 497
	ir@anandadevelopments.com
Chief Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	+44 (0)20 3470 0470
Corporate Finance
Richard Morrison
Caroline Rowe
Corporate Broking
Abigail Wayne
Rob Rees
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay	+44 (0)20 3004 9512 ananda@yellowjerseypr.com

https://investors.anandapharma.co.uk/link/MP704y

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFLFVRFFIVIIE